Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial.
J Immunother Cancer. 2020 Nov;8(2):e001157. doi: 10.1136/jitc-2020-001157.
J Immunother Cancer. 2020.
PMID: 33184050
Free PMC article.
Clinical Trial.